Equity Capital Markets

Company · CIK 1982708

Anbio Biotechnology

CIK1982708 (SEC EDGAR)
Industry (SIC)2835 — In Vitro & In Vivo Diagnostic Substances
Incorporated inE9
Business addressGermany
ListedNNNN (Nasdaq)
First annual or quarterly report2025-04-28

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-284106
IPOFinal prospectus
 2024-12-312025-02-196

Filings

7
FiledFilingRegistrationAccession
2025-02-19424B4Final prospectus 333-2841060001213900-25-015001
2025-02-18EFFECTDeclared effective 333-2841069999999995-25-000497
2025-02-10F-1/AAmendment 333-2841060001213900-25-011623
2025-01-24F-1/AAmendment 333-2841060001213900-25-006373
2025-01-10F-1/AAmendment 333-2841060001213900-25-002551
2024-12-31F-1Registration filed 333-2841060001213900-24-114129
2023-12-27DRSDraft made public 377-070310001213900-23-098831

All filings of this company · CSV